Age-adjusted prevalence of type two diabetes
| Finnish | Russian | Somali | Kurdish | |
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
| Men, N | 395 | 119 | 85 | 181 |
| Type 2 diabetes† | 6.2 (4.4 to 8.7) | 4.3 (1.8 to 10.0) | 15.5 (8.5 to 26.7)* | 10.5 (7.0 to 15.4) |
| Self-reported diabetes | 5.1 (3.4 to 7.5) | 3.5 (1.3 to 9.2) | 8.2 (3.4 to 18.4) | 8.8 (5.6 to 13.6) |
| Register-based diabetes‡ | 6.0 (4.2 to 8.5) | 4.3 (1.8 to 10.0) | 12.3 (6.0 to 23.5) | 9.7 (6.3 to 14.5) |
| HbA1c ≥6.5% (140 mg/dL) | 2.0 (1.0 to 4.0) | 0.7 (0.1 to 4.7) | 8.2 (3.4 to 18.5)* | 4.7 (2.4 to 8.8) |
| Women | 492 | 225 | 140 | 167 |
| Type 2 diabetes† | 3.5 (2.3 to 5.5) | 6.0 (3.4 to 10.4) | 16.4 (10.6 to 24.5)*** | 11.8 (7.8 to 17.4)*** |
| Self-reported diabetes | 2.6 (1.5 to 4.3) | 4.6 (2.5 to 8.4) | 14.6 (8.9 to 23.0)*** | 11.2 (7.3 to 16.8)*** |
| Register-based diabetes‡ | 3.1 (1.9 to 4.9) | 3.3 (1.6 to 6.6) | 10.5 (6.0 to 17.8)** | 8.1 (4.8 to 13.3)** |
| HbA1c ≥6.5% (140 mg/dL) | 1.7 (0.8 to 3.4) | 1.8 (0.6 to 5.6) | 5.1 (2.1 to 12.0) | 2.5 (0.8 to 7.0) |
P value is presented for the difference between each migrant group and Finns.
*P<0.5, **P<0.001, ***P<0.001.
†Type 2 diabetes: self-reported diagnosis by a physician and/or self-reported diabetes medications and/or register-based diabetes and/or HbA1c ≥140mg/dL.
‡Register-based diabetes: register-based data on special medication reimbursement rights for diabetes medicine and/or inpatient or outpatient hospital care/physician visits for diabetes treatment.
HbA1c, glycated haemoglobin.